Activity Overview
This video-based program is designed to provide education on identifying hypercortisolism using a unique format in which the potential consequences of a delayed diagnosis will be revealed using patient-clinician interaction videos. The faculty will focus on recognizing subclinical or atypical presentations of hypercortisolism, as well as appropriate screening steps if hypercortisolism is suspected.
Target Audience
This educational activity is directed toward cardiologists, endocrinologists, primary care physicians, NPs, PAs, and other health care professionals involved in the management of hypercortisolism.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Apply screening recommendations to identify hypercortisolism in patients with comorbidities
- Implement strategies to confirm the diagnosis of hypercortisolism in patients with comorbidities

Yehuda Handelsman, MD, FACP, FNLA, FASPC, FAHA, MACE
Medical Director and Principal Investigator
Metabolic Institute of America
Adjunct Clinical Professor of Medicine,
Charles Drew University
Los Angeles, CA
Disclosures: Adviser, Consultant, Fee for Service: Amgen, Arrowhead, AZ, Bayer, BI, Corcept, Regeneron, Sanofi, Verdiva Bio. Speakers Bureau: Boehringer Ingelheim, Novo Nordisk. Grant/Research Funding: AZ, Corcept, Ionis, Merck, Regeneron, Verdiva Bio.
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
